Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts

Transforming growth factor-β (TGF-β) signaling is essential in embryo development and maintaining normal homeostasis. Extensive evidence shows that TGF-β activation acts on several cell types, including epithelial cells, fibroblasts, and immune cells, to form a pro-fibrotic environment, ultimately l...

Full description

Bibliographic Details
Main Authors: Xueke Shi, Christian D. Young, Hongmei Zhou, Xiao-Jing Wang
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/12/1666
_version_ 1797544874671603712
author Xueke Shi
Christian D. Young
Hongmei Zhou
Xiao-Jing Wang
author_facet Xueke Shi
Christian D. Young
Hongmei Zhou
Xiao-Jing Wang
author_sort Xueke Shi
collection DOAJ
description Transforming growth factor-β (TGF-β) signaling is essential in embryo development and maintaining normal homeostasis. Extensive evidence shows that TGF-β activation acts on several cell types, including epithelial cells, fibroblasts, and immune cells, to form a pro-fibrotic environment, ultimately leading to fibrotic diseases. TGF-β is stored in the matrix in a latent form; once activated, it promotes a fibroblast to myofibroblast transition and regulates extracellular matrix (ECM) formation and remodeling in fibrosis. TGF-β signaling can also promote cancer progression through its effects on the tumor microenvironment. In cancer, TGF-β contributes to the generation of cancer-associated fibroblasts (CAFs) that have different molecular and cellular properties from activated or fibrotic fibroblasts. CAFs promote tumor progression and chronic tumor fibrosis via TGF-β signaling. Fibrosis and CAF-mediated cancer progression share several common traits and are closely related. In this review, we consider how TGF-β promotes fibrosis and CAF-mediated cancer progression. We also discuss recent evidence suggesting TGF-β inhibition as a defense against fibrotic disorders or CAF-mediated cancer progression to highlight the potential implications of TGF-β-targeted therapies for fibrosis and cancer.
first_indexed 2024-03-10T14:07:40Z
format Article
id doaj.art-45b95ae77fef4fb7a00802c07f244a92
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T14:07:40Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-45b95ae77fef4fb7a00802c07f244a922023-11-21T00:31:58ZengMDPI AGBiomolecules2218-273X2020-12-011012166610.3390/biom10121666Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated FibroblastsXueke Shi0Christian D. Young1Hongmei Zhou2Xiao-Jing Wang3State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, ChinaDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USAState Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, ChinaDepartment of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USATransforming growth factor-β (TGF-β) signaling is essential in embryo development and maintaining normal homeostasis. Extensive evidence shows that TGF-β activation acts on several cell types, including epithelial cells, fibroblasts, and immune cells, to form a pro-fibrotic environment, ultimately leading to fibrotic diseases. TGF-β is stored in the matrix in a latent form; once activated, it promotes a fibroblast to myofibroblast transition and regulates extracellular matrix (ECM) formation and remodeling in fibrosis. TGF-β signaling can also promote cancer progression through its effects on the tumor microenvironment. In cancer, TGF-β contributes to the generation of cancer-associated fibroblasts (CAFs) that have different molecular and cellular properties from activated or fibrotic fibroblasts. CAFs promote tumor progression and chronic tumor fibrosis via TGF-β signaling. Fibrosis and CAF-mediated cancer progression share several common traits and are closely related. In this review, we consider how TGF-β promotes fibrosis and CAF-mediated cancer progression. We also discuss recent evidence suggesting TGF-β inhibition as a defense against fibrotic disorders or CAF-mediated cancer progression to highlight the potential implications of TGF-β-targeted therapies for fibrosis and cancer.https://www.mdpi.com/2218-273X/10/12/1666TGF-β signalingfibroblastsfibrotic diseasescancercancer-associated fibroblastanti-fibrosis/cancer therapy
spellingShingle Xueke Shi
Christian D. Young
Hongmei Zhou
Xiao-Jing Wang
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Biomolecules
TGF-β signaling
fibroblasts
fibrotic diseases
cancer
cancer-associated fibroblast
anti-fibrosis/cancer therapy
title Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
title_full Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
title_fullStr Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
title_full_unstemmed Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
title_short Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
title_sort transforming growth factor β signaling in fibrotic diseases and cancer associated fibroblasts
topic TGF-β signaling
fibroblasts
fibrotic diseases
cancer
cancer-associated fibroblast
anti-fibrosis/cancer therapy
url https://www.mdpi.com/2218-273X/10/12/1666
work_keys_str_mv AT xuekeshi transforminggrowthfactorbsignalinginfibroticdiseasesandcancerassociatedfibroblasts
AT christiandyoung transforminggrowthfactorbsignalinginfibroticdiseasesandcancerassociatedfibroblasts
AT hongmeizhou transforminggrowthfactorbsignalinginfibroticdiseasesandcancerassociatedfibroblasts
AT xiaojingwang transforminggrowthfactorbsignalinginfibroticdiseasesandcancerassociatedfibroblasts